First Report of Clostridium difficile NAP1/027 in a Mexican Hospital

Background and Objective Clostridium difficile NAP1/ribotype 027 is associated with severe disease and high mortality rates. Our aim was to determine the prevalence of NAP1/ribotype 027 among C. difficile isolates in a tertiary care hospital, and review the main clinical data. Methods We includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Heimesaat, Markus M., Camacho Ortiz, Adrián, López Barrera, Daniel, Hernández García, Raúl, Galván de los Santos, Alejandra María, Flores Treviño, Samantha Maribel, Llaca Díaz, Jorge Martín, Maldonado Garza, Héctor Jesús, Bosques Padilla, Francisco Javier, Garza González, Elvira
Formato: Artículo
Lenguaje:inglés
Publicado: Public Library of Science 2015
Acceso en línea:http://eprints.uanl.mx/14958/1/129.PDF
_version_ 1824414204897001472
author Heimesaat, Markus M.
Camacho Ortiz, Adrián
López Barrera, Daniel
Hernández García, Raúl
Galván de los Santos, Alejandra María
Flores Treviño, Samantha Maribel
Llaca Díaz, Jorge Martín
Maldonado Garza, Héctor Jesús
Bosques Padilla, Francisco Javier
Garza González, Elvira
author_facet Heimesaat, Markus M.
Camacho Ortiz, Adrián
López Barrera, Daniel
Hernández García, Raúl
Galván de los Santos, Alejandra María
Flores Treviño, Samantha Maribel
Llaca Díaz, Jorge Martín
Maldonado Garza, Héctor Jesús
Bosques Padilla, Francisco Javier
Garza González, Elvira
author_sort Heimesaat, Markus M.
collection Repositorio Institucional
description Background and Objective Clostridium difficile NAP1/ribotype 027 is associated with severe disease and high mortality rates. Our aim was to determine the prevalence of NAP1/ribotype 027 among C. difficile isolates in a tertiary care hospital, and review the main clinical data. Methods We included 106 stool samples from 106 patients. Samples were tested for A&B toxins and were cultured on CCFA agar. The genes tcdA, tcdB, tcdC, cdtA, and cdtB were amplified using PCR in clinical isolates. The tcdA 3’-end deletion analysis, PCR-ribotyping, and pulsed-field gel electrophoresis (PFGE) were also performed. Stool samples that were positive for culture were tested by the GeneXpert C. difficile assay. Clinical data were collected. Results Thirty-six patients tested positive for A&B toxins; and 22 patients had positive culture for C. difficile, 14 of which tested positive for the A&B toxins and all 22 patients tested positive by the GeneXpert C. difficile assay. Risk factors included an average hospital stay of 16.1 days prior to toxin detection, average antibiotic use for 16.2 days, and a median of 3 antibiotics used. The 30-day crude mortality rate was 8.4%. Six of the 22 patients died, and 3 of those deaths were directly attributed to C. difficile infection. The majority of isolates, 90.9% (20/22), carried genes tcdB, tcdA, cdtA, and cdtB; and these strains carried the corresponding downregulator gene tcdC, with an 18-bp deletion. PFGE was performed on 17 isolates, and one main pattern was observed. Analysis of the ribotyping data showed similar results. Conclusion The above findings represent the clonal spread of C. difficile in our institution, which mainly includes the NAP1/027 strain. This is the first report of C. difficile ribotype NAP1/027 in Mexico
format Article
id eprints-14958
institution UANL
language English
publishDate 2015
publisher Public Library of Science
record_format eprints
spelling eprints-149582024-12-09T19:49:55Z http://eprints.uanl.mx/14958/ First Report of Clostridium difficile NAP1/027 in a Mexican Hospital Heimesaat, Markus M. Camacho Ortiz, Adrián López Barrera, Daniel Hernández García, Raúl Galván de los Santos, Alejandra María Flores Treviño, Samantha Maribel Llaca Díaz, Jorge Martín Maldonado Garza, Héctor Jesús Bosques Padilla, Francisco Javier Garza González, Elvira Background and Objective Clostridium difficile NAP1/ribotype 027 is associated with severe disease and high mortality rates. Our aim was to determine the prevalence of NAP1/ribotype 027 among C. difficile isolates in a tertiary care hospital, and review the main clinical data. Methods We included 106 stool samples from 106 patients. Samples were tested for A&B toxins and were cultured on CCFA agar. The genes tcdA, tcdB, tcdC, cdtA, and cdtB were amplified using PCR in clinical isolates. The tcdA 3’-end deletion analysis, PCR-ribotyping, and pulsed-field gel electrophoresis (PFGE) were also performed. Stool samples that were positive for culture were tested by the GeneXpert C. difficile assay. Clinical data were collected. Results Thirty-six patients tested positive for A&B toxins; and 22 patients had positive culture for C. difficile, 14 of which tested positive for the A&B toxins and all 22 patients tested positive by the GeneXpert C. difficile assay. Risk factors included an average hospital stay of 16.1 days prior to toxin detection, average antibiotic use for 16.2 days, and a median of 3 antibiotics used. The 30-day crude mortality rate was 8.4%. Six of the 22 patients died, and 3 of those deaths were directly attributed to C. difficile infection. The majority of isolates, 90.9% (20/22), carried genes tcdB, tcdA, cdtA, and cdtB; and these strains carried the corresponding downregulator gene tcdC, with an 18-bp deletion. PFGE was performed on 17 isolates, and one main pattern was observed. Analysis of the ribotyping data showed similar results. Conclusion The above findings represent the clonal spread of C. difficile in our institution, which mainly includes the NAP1/027 strain. This is the first report of C. difficile ribotype NAP1/027 in Mexico Public Library of Science 2015 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/14958/1/129.PDF http://eprints.uanl.mx/14958/1.haspreviewThumbnailVersion/129.PDF Heimesaat, Markus M. y Camacho Ortiz, Adrián y López Barrera, Daniel y Hernández García, Raúl y Galván de los Santos, Alejandra María y Flores Treviño, Samantha Maribel y Llaca Díaz, Jorge Martín y Maldonado Garza, Héctor Jesús y Bosques Padilla, Francisco Javier y Garza González, Elvira (2015) First Report of Clostridium difficile NAP1/027 in a Mexican Hospital. PloS one, 10 (4). e0122627. ISSN 1932-6203 http://doi.org/10.1371/journal.pone.0122627 doi:10.1371/journal.pone.0122627
spellingShingle Heimesaat, Markus M.
Camacho Ortiz, Adrián
López Barrera, Daniel
Hernández García, Raúl
Galván de los Santos, Alejandra María
Flores Treviño, Samantha Maribel
Llaca Díaz, Jorge Martín
Maldonado Garza, Héctor Jesús
Bosques Padilla, Francisco Javier
Garza González, Elvira
First Report of Clostridium difficile NAP1/027 in a Mexican Hospital
thumbnail https://rediab.uanl.mx/themes/sandal5/images/online.png
title First Report of Clostridium difficile NAP1/027 in a Mexican Hospital
title_full First Report of Clostridium difficile NAP1/027 in a Mexican Hospital
title_fullStr First Report of Clostridium difficile NAP1/027 in a Mexican Hospital
title_full_unstemmed First Report of Clostridium difficile NAP1/027 in a Mexican Hospital
title_short First Report of Clostridium difficile NAP1/027 in a Mexican Hospital
title_sort first report of clostridium difficile nap1 027 in a mexican hospital
url http://eprints.uanl.mx/14958/1/129.PDF
work_keys_str_mv AT heimesaatmarkusm firstreportofclostridiumdifficilenap1027inamexicanhospital
AT camachoortizadrian firstreportofclostridiumdifficilenap1027inamexicanhospital
AT lopezbarreradaniel firstreportofclostridiumdifficilenap1027inamexicanhospital
AT hernandezgarciaraul firstreportofclostridiumdifficilenap1027inamexicanhospital
AT galvandelossantosalejandramaria firstreportofclostridiumdifficilenap1027inamexicanhospital
AT florestrevinosamanthamaribel firstreportofclostridiumdifficilenap1027inamexicanhospital
AT llacadiazjorgemartin firstreportofclostridiumdifficilenap1027inamexicanhospital
AT maldonadogarzahectorjesus firstreportofclostridiumdifficilenap1027inamexicanhospital
AT bosquespadillafranciscojavier firstreportofclostridiumdifficilenap1027inamexicanhospital
AT garzagonzalezelvira firstreportofclostridiumdifficilenap1027inamexicanhospital